These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 33253282)
61. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568 [TBL] [Abstract][Full Text] [Related]
62. The prognostic impact of differentiation at the invasive front of biliary tract cancer. Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828 [TBL] [Abstract][Full Text] [Related]
63. Right hepatic artery interruption and prostaglandin E1 in total or proximal pancreatectomy for pancreatobiliary malignancy. Yoshida T; Aramaki M; Matsumoto T; Morii Y; Bandah T; Kai T; Kawano K; Kitano S Hepatogastroenterology; 2001; 48(40):1166-9. PubMed ID: 11490825 [TBL] [Abstract][Full Text] [Related]
64. How to improve pre-operative diagnostics of pancreatobiliary lesions? From immunohistochemistry to Next Generation Sequencing. Švajdler M; Daum O; Daumová M; Pintová J; Procházka R Cesk Patol; 2024; 60(2):90-101. PubMed ID: 39138011 [TBL] [Abstract][Full Text] [Related]
65. Differential features of pancreatobiliary- and intestinal-type ampullary carcinomas at MR imaging. Chung YE; Kim MJ; Park MS; Choi JY; Kim H; Kim SK; Lee M; Kim HJ; Choi JS; Song SY; Kim KW Radiology; 2010 Nov; 257(2):384-93. PubMed ID: 20829529 [TBL] [Abstract][Full Text] [Related]
67. Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer. Kawamata H; Yamashita K; Nakamura K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Kumamoto Y; Watanabe M Anticancer Res; 2013 Feb; 33(2):583-94. PubMed ID: 23393352 [TBL] [Abstract][Full Text] [Related]
68. MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers. Kim J; Ryu JK; Lee SH; Kim YT Gut Liver; 2016 Sep; 10(5):836-41. PubMed ID: 27172928 [TBL] [Abstract][Full Text] [Related]
69. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion. Ahn G; Folkins AK; McKenney JK; Longacre TA Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741 [TBL] [Abstract][Full Text] [Related]
70. Reevaluating significance of perineural invasion in gastric cancer based on double immunohistochemical staining. Zhou ZH; Xu GF; Zhang WJ; Zhao HB; Wu YY Arch Pathol Lab Med; 2014 Feb; 138(2):229-34. PubMed ID: 24476520 [TBL] [Abstract][Full Text] [Related]
71. Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression. Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C Hum Pathol; 2004 Feb; 35(2):176-83. PubMed ID: 14991534 [TBL] [Abstract][Full Text] [Related]
72. The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of pancreatico-biliary cancers--A meta-analysis. Hariharan D; Constantinides VA; Froeling FE; Tekkis PP; Kocher HM Eur J Surg Oncol; 2010 Oct; 36(10):941-8. PubMed ID: 20547445 [TBL] [Abstract][Full Text] [Related]
73. CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses. Sakai Y; Hong SM; An S; Kim JY; Corbeil D; Karbanová J; Otani K; Fujikura K; Song KB; Kim SC; Akita M; Nanno Y; Toyama H; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y Hum Pathol; 2017 Mar; 61():148-157. PubMed ID: 27864124 [TBL] [Abstract][Full Text] [Related]
74. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812 [TBL] [Abstract][Full Text] [Related]
75. Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists. Kirsch R; Messenger DE; Riddell RH; Pollett A; Cook M; Al-Haddad S; Streutker CJ; Divaris DX; Pandit R; Newell KJ; Liu J; Price RG; Smith S; Parfitt JR; Driman DK Am J Surg Pathol; 2013 Feb; 37(2):200-10. PubMed ID: 23108018 [TBL] [Abstract][Full Text] [Related]
76. [The tumoural pathology of the pancreatobiliary ductal system (author's transl)]. Bellassai J; Haot J Acta Gastroenterol Belg; 1981; 44(5-6):215-24. PubMed ID: 7293683 [No Abstract] [Full Text] [Related]
77. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078 [TBL] [Abstract][Full Text] [Related]
78. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters. Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385 [TBL] [Abstract][Full Text] [Related]
79. [Principles and value of lymph node excision in tumors of the pancreatobiliary system]. Schumpelick V; Kasperk R Chirurg; 1996 Sep; 67(9):900-6. PubMed ID: 8991770 [TBL] [Abstract][Full Text] [Related]
80. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Yao Y; Kubota T; Takeuchi H; Sato K Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]